10 Sep Risk Protocol Identifies Patients with Cancer Not Allergic to Carboplatin Posted at 13:36h in Infectious and Immunologic Disease by Research at Brigham and Women's Hospital 3 Likes Share Dr. Alberta Wang’s study on a new protocol to identify patients who are not allergic to carboplatin and oxaliplatin is covered by Healio Allergy/Immunology.
